Overview
- Officials announced installation of a second isotope production system at CANDU Unit 6 in Tiverton, expanding Bruce Power’s capacity to produce lutetium‑177.
- Bruce Power plans to file a licence application by year‑end to enable on‑site preparation for pharmaceutical processing, which is currently done in Germany.
- Work on the Unit 6 expansion is expected to begin in the second quarter of 2026, pending regulatory approvals.
- The project is framed as a partnership with the Saugeen Ojibway Nation to advance economic participation and reconciliation outcomes.
- Funding flows through the Canadian Medical Isotope Ecosystem, created in 2023 under the Strategic Innovation Fund, as Ottawa links the move to broader life‑sciences investments.